Sunrest Lifescience Ltd
Fundamental Score
Sunrest Lifescience Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SUNREST across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 10.42 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Strong Revenue Growth (120.99%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Strong Interest Coverage (9.45x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (53.50%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
3 factors identified
Profit Decline Concern (-41.38%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Sunrest Lifescience Ltd
About SUNREST
Company Details
SUNREST Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Sunrest Lifescience Ltd (SUNREST)?
As of 29 Jan 2026, 10:34 am IST, Sunrest Lifescience Ltd (SUNREST) is currently trading at ₹33.00. The stock has a market capitalization of ₹18.45 (Cr).
Is SUNREST share price Overvalued or Undervalued?
SUNREST is currently trading at a P/E ratio of 10.42x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Sunrest Lifescience Ltd share price?
Key factors influencing SUNREST's price include its quarterly earnings growth (Sales Growth: 120.99%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Sunrest Lifescience Ltd a good stock for long-term investment?
Sunrest Lifescience Ltd shows a 5-year Profit Growth of N/A% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.94 before investing.
How does Sunrest Lifescience Ltd compare with its industry peers?
Sunrest Lifescience Ltd competes with major peers in the Pharmaceuticals. Investors should compare SUNREST's P/E of 10.42x and ROE of N/A% against the industry averages to determine its competitive standing.
What is the P/E ratio of SUNREST and what does it mean?
SUNREST has a P/E ratio of 10.42x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹10 for every ₹1 of annual earnings.
How is SUNREST performing according to Bull Run's analysis?
SUNREST has a Bull Run fundamental score of 5.9/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does SUNREST belong to?
SUNREST operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sunrest Lifescience Ltd.
What is Return on Equity (ROE) and why is it important for SUNREST?
SUNREST has an ROE of N/A%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Sunrest Lifescience Ltd generates profits from shareholders' equity.
How is SUNREST's debt-to-equity ratio and what does it indicate?
SUNREST has a debt-to-equity ratio of 0.94, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is SUNREST's dividend yield and is it a good dividend stock?
SUNREST offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has SUNREST grown over the past 5 years?
SUNREST has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in SUNREST and why does it matter?
Promoters hold 53.50% of SUNREST shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is SUNREST's market capitalization category?
SUNREST has a market capitalization of ₹18 crores, placing it in the Small-cap category.
How volatile is SUNREST stock?
SUNREST has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for SUNREST?
SUNREST has a 52-week high of ₹N/A and low of ₹N/A.
What is SUNREST's operating profit margin trend?
SUNREST has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is SUNREST's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 120.99% and YoY Profit Growth of -41.38%.
What is the institutional holding pattern in SUNREST?
SUNREST has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.